Pulmonary Arterial Hypertension (PAH) Treatment Market Size, Share and Global Trend By Drug Class (Soluble Guanylate Cyclase (SGC) Stimulators,Prostacyclin and Prostacyclin Analogs, Phosphodiesterase 5 (PDE-5), Endothelin Receptor Antagonists (ERA)), By End User (Hospitals, Clinics, Others), and Regional Forecast, 2024-2032
Report Id | License Type | Price |
---|---|---|
FBI101003 | $ 4850 | |
Total | $ 4850 |